Chyong N.

Chyong N. is an experienced clinical development leader with a robust background in ophthalmology and clinical science. Currently serving as Executive Director of Clinical Development at Ocular Therapeutix, Inc. since July 2024, Chyong has previously held significant roles including Senior Medical Director and Medical Director at 4D Molecular Therapeutics between February 2022 and July 2024, as well as Medical Director at Gemini Therapeutics. Other notable positions include Director of Clinical Science at Santen, Clinical Science Manager at Aerie Pharmaceuticals, and Clinical Development Contractor at Allergan. Chyong's early career includes key roles as Clinical Programs Principal Scientist at TearScience, Manager of Clinical Affairs at OD-OS Inc, and an Ophthalmology Research-Postdoctoral Scholar at the Gavin Herbert Eye Institute. Chyong holds an MD from Pontificia Universidad Católica de Chile and completed an Ophthalmology Residency Program at Universidad de los Andes.